Literature DB >> 14985302

Central immunotolerance in transgenic mice expressing a foreign antigen under control of the rhodopsin promoter.

Don-Il Ham1, Stephen J Kim, Jun Chen, Barbara P Vistica, Robert N Fariss, Robert S Lee, Eric F Wawrousek, Hiroshi Takase, Cheng-Rong Yu, Charles E Egwuagu, Chi-Chao Chan, Igal Gery.   

Abstract

PURPOSE: Different conclusions have been reached in recent studies concerning the immune response or tolerance of transgenic (Tg) mice expressing foreign antigens under control of retinal antigen promoters. The present study was aimed at analyzing the state of tolerance in Tg mice expressing hen egg lysozyme (HEL) under control of the rhodopsin promoter.
METHODS: Tg mice expressing HEL under control of the rhodopsin promoter (RhHEL-Tg) were generated and tested by conventional methods for immune responses against HEL. These Tg mice were also mated with Tg mice expressing HEL-specific receptor on their T lymphocytes and the double-Tg mice were examined for increased apoptosis in their thymi by the TUNEL assay, as well as for loss of HEL-specific T cells, by flow cytometry and proliferative response. The presence of HEL mRNA in mouse thymi was determined by RT-PCR.
RESULTS: RhHEL-Tg mice developed tolerance to HEL, shown by reduced cellular and humoral responses to HEL, as well as by the failure of ocular inflammation to develop after immunization with HEL. RhHEL-Tg mice expressed HEL mRNA in their thymus, and the tolerogenic mechanism in these mice was shown to be thymic deletion of HEL-specific T cells by the following observations in the double-Tg mice: (1) increased apoptosis in their thymi, (2) remarkable reduction in the proportion of the HEL-specific T cells, and (3) loss of lymphocyte response to low concentrations of HEL.
CONCLUSIONS: Tg mice expressing HEL under control of the rhodopsin promoter develop a tolerance for the foreign antigen, apparently as a result of thymic expression of HEL and deletion of T cells specific to this antigen.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985302     DOI: 10.1167/iovs.03-1028

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model.

Authors:  W-Y Shen; C M Lai; C E Graham; N Binz; Y K Y Lai; J Eade; D Guidolin; D Ribatti; S A Dunlop; P E Rakoczy
Journal:  Diabetologia       Date:  2006-05-10       Impact factor: 10.122

2.  Generation of Regulatory T Cells to Antigen Expressed in the Retina.

Authors:  Scott W McPherson; Neal D Heuss; Ute Lehman; Dale S Gregerson
Journal:  Curr Immunol Rev       Date:  2011

Review 3.  A look at autoimmunity and inflammation in the eye.

Authors:  Rachel R Caspi
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

4.  Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation.

Authors:  Cheng-Rong Yu; Rashid R Mahdi; Hyun-Mee Oh; Ahjoku Amadi-Obi; Grace Levy-Clarke; Jenna Burton; Amarachi Eseonu; Yongjun Lee; Chi-Chao Chan; Charles E Egwuagu
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-01       Impact factor: 4.799

5.  Thymic expression of peripheral tissue antigens in humans: a remarkable variability among individuals.

Authors:  Hiroshi Takase; Cheng-Rong Yu; Rashid M Mahdi; Daniel C Douek; Gregory B Dirusso; Frank M Midgley; Rajpreet Dogra; Gloria Allende; Eliot Rosenkranz; Alberto Pugliese; Charles E Egwuagu; Igal Gery
Journal:  Int Immunol       Date:  2005-07-19       Impact factor: 4.823

6.  Suppressors of cytokine-signaling proteins induce insulin resistance in the retina and promote survival of retinal cells.

Authors:  Xuebin Liu; Marie G Mameza; Yun Sang Lee; Chikezie I Eseonu; Cheng-Rong Yu; Jennifer J Kang Derwent; Charles E Egwuagu
Journal:  Diabetes       Date:  2008-03-20       Impact factor: 9.461

7.  Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen.

Authors:  Reiko Horai; Phyllis B Silver; Jun Chen; Rajeev K Agarwal; Wai Po Chong; Yingyos Jittayasothorn; Mary J Mattapallil; Sonia Nguyen; Kannan Natarajan; Rafael Villasmil; Peng Wang; Zaruhi Karabekian; Simon D Lytton; Chi-Chao Chan; Rachel R Caspi
Journal:  J Autoimmun       Date:  2013-06-28       Impact factor: 7.094

8.  Lymphopenia-induced proliferation is a potent activator for CD4+ T cell-mediated autoimmune disease in the retina.

Authors:  Scott W McPherson; Neal D Heuss; Dale S Gregerson
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

9.  Regulation of CD8(+) T Cell Responses to Retinal Antigen by Local FoxP3(+) Regulatory T Cells.

Authors:  Scott W McPherson; Neal D Heuss; Dale S Gregerson
Journal:  Front Immunol       Date:  2012-06-21       Impact factor: 7.561

10.  Investigation of the relationship between the onset of arthritis and uveitis in genetically predisposed SKG mice.

Authors:  Ellen J Lee; Emily E Vance; Brieanna R Brown; Paige S Snow; Jenna S Clowers; Shimon Sakaguchi; Holly L Rosenzweig
Journal:  Arthritis Res Ther       Date:  2015-08-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.